Summary
Eiko Lifesciences share holding pattern reports the following shareholding: Eiko Lifesciences Total Promoters is at 39.91%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 60.09%. This breakdown provides a quick snapshot of ownership distribution for Eiko Lifesciences share holding pattern in 2026-27.
Eiko Lifesciences FAQs
As of 05-2026, the promoter shareholding in Eiko Lifesciences stands at 39.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Eiko Lifesciences is 0% and 0% respectively.
The retail shareholding of the Eiko Lifesciences is 60.09%.
Changes in shareholding patterns of Eiko Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Eiko Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
